William E. Duke - 07 Oct 2022 Form 4 Insider Report for Apexigen, Inc.

Reporting relationship: Chief Financial Officer
Issuer ticker: N/A
Reported as of: 07 Oct 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Oct 2022, 16:50:25 UTC
Prior SEC filing: 08 Aug 2022
Next SEC filing: 19 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Francis Sarena, by power of attorney

Key filing fact

William E. Duke filed Form 4 for Apexigen, Inc. on 11 Oct 2022.

Key facts

This page summarizes William E. Duke's Form 4 filing for Apexigen, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Oct 2022, 16:50.

Change

Previous filing in this sequence was filed on 08 Aug 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APGN transaction

Common Stock

Award

Transaction value: $0
Shares: +30,685
Change %
Price: $0.000000
Shares after: 30,685
Date: 07 Oct 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APGN transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +269,848
Change %
Price: $0.000000
Shares after: 269,848
Date: 07 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 269,848
Exercise price: $2.46
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares are represented by restricted stock units, or RSUs, which vest in two equal installments on December 15, 2022 and June 15, 2023.

Footnote F2

One-fourth of the shares vest on June 6, 2023 and 1/48th of the shares vest monthly thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .